EE348 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Costa Rica

Abstract

Authors

J Ordoñez F Hernández G Rodríguez J Estrada A Ordóñez J Hidalgo Godínez K Villalobos

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×